Full Press Release Details
jpmpresentation2018.
PTCT
jpmpresentation2018
Key Takeaway: jpmpresentation2018
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+74%
120-day peak, hindsight
Typical move
6.6%
average across 4 past catalysts
Lead asset
Ataluren
Phase 3 · Cystic Fibrosis